Viridian Therapeutics, Inc.\DE (VRDN) Capital expenditures 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$495,000FY2025 · since FY2016: $250,000 → $495,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $495,000 | -3.1% |
| FY2024 | $511,000 | -43.1% |
| FY2023 | $898,000 | +12.7% |
| FY2022 | $797,000 | +135.8% |
| FY2021 | $338,000 | +704.8% |
| FY2020 | $42,000 | -50.0% |
| FY2019 | $84,000 | -81.1% |
| FY2018 | $445,000 | +80.9% |
| FY2017 | $246,000 | -1.6% |
| FY2016 | $250,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice